Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis
Open Access
- 8 December 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (12), 4002-4007
- https://doi.org/10.1002/art.20674
Abstract
Objective CD19 is overexpressed in B cells from patients with systemic sclerosis (SSc), and plays a crucial role not only for autoantibody production, but also for skin fibrosis in mouse models. We previously reported the association of a GT repeat polymorphism in the 3′-untranslated region (3′-UTR) of CD19 with human systemic lupus erythematosus. In this study, we examined whether CD19 polymorphisms are associated with genetic susceptibility to SSc. Methods A case–control association study was performed for CD19 polymorphisms, −499G>T in the promoter region and a GT repeat polymorphism in the 3′-UTR, in 134 patients with SSc and 96 healthy individuals recruited at Kanazawa University. CD19 expression levels in the peripheral blood naive and memory B cells from SSc patients were examined by 2-color flow cytometry. Results Carrier frequencies of the −499T allele in the promoter (odds ratio [OR] 2.18, 95% confidence interval [95% CI] 1.31–3.86, P = 0.003) and of the (GT)14 allele in the 3′-UTR (OR 1.86, 95% CI 1.05–3.28, P = 0.03) were significantly increased in SSc patients compared with healthy controls. Association was particularly evident in patients with limited cutaneous SSc with anticentromere antibodies. These alleles were in linkage disequilibrium, but the −499T allele seemed to play a primary role. CD19 expression levels in peripheral blood B cells were significantly elevated in both naive (P = 0.0029) and memory (P = 0.0022) B cells from patients with SSc who had the −499T allele as compared with those without the −499T allele. Conclusion The CD19 −499G>T polymorphism is associated with higher CD19 expression in B cells, and with susceptibility to SSc.Keywords
This publication has 22 references indexed in Scilit:
- Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cellsArthritis & Rheumatism, 2004
- Meta‐analysis of four rheumatoid arthritis genome‐wide linkage studies: Confirmation of a susceptibility locus on chromosome 16Arthritis & Rheumatism, 2003
- Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese populationArthritis & Rheumatism, 2003
- Polymorphisms of human CD19 gene: possible association with susceptibility to systemic lupus erythematosus in JapaneseGenes & Immunity, 2002
- CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouseJCI Insight, 2002
- Genome Screening in Human Systemic Lupus Erythematosus: Results from a Second Minnesota Cohort and Combined Analyses of 187 Sib-Pair FamiliesAmerican Journal of Human Genetics, 2000
- Databases on transcriptional regulation: TRANSFAC, TRRD and COMPELNucleic Acids Research, 1998
- The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and AutoimmunityImmunity, 1997
- Increased prevalence of systemic sclerosis in a native american tribe in oklahoma. Association with an amerindian HLA haplotypeArthritis & Rheumatism, 1996
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980